Summit Partners Invests €31 million to Fuel Growth at Signavio
Signavio GmbH – a leading provider of SaaS-based business process and decision management technology – today announced the completion of a €31 million minority investment from global growth equity investor Summit Partners . The investment will help Signavio expand its international footprint and continue its very strong growth trajectory.
Founded in 2009, with offices in Berlin, Singapore and Sunnyvale, Signavio is a provider of cloud-based software that helps businesses efficiently design, implement and manage complex processes, decisions and workflows. With its three products – Process Editor, Decision Manager and Effektif – Signavio offers an intuitive and collaborative process transformation platform, enabling company-wide compliance, process performance and process innovation initiatives. Today the company serves over 750 corporations, businesses, and organizations around the world in industries ranging from manufacturing to financial services.
“This is a significant milestone for Signavio,” commented founder and CEO, Gero Decker. “We believe strongly that our differentiated approach is changing the way that our customers are optimizing and executing key strategic business initiatives, and we are excited to work with the Summit team in our next phase of growth. With their support, we are focused on continuing our record of product innovation and further strengthening our sales and service capabilities around the world.”
“Gero and his team have done a remarkable job of distinguishing Signavio as top of the class in next generation business process and decision management solutions,” said Scott Collins, a Managing Director at Summit Partners. “Summit has a history of backing innovative, market-leading companies that are poised for great success. With its SaaS delivery model, open standards architecture, and end-to-end product suite, we believe there is an enormous future for Signavio, and we look forward to working with the team to grow the business in Europe, North America and Asia.”
Signavio was advised in the transaction by GP Bullhound and CMS. Summit Partners was advised by Hengeler Mueller and Kirkland & Ellis. Further details of the transaction were not disclosed.
Signavio offers a web-based solution for modeling, analyzing, and optimizing business processes and decisions. As a leading vendor for SaaS software for company-wide process and decision management, Signavio combines the richness of a professional business process management (BPM) and business decision management (BDM) solution with the advantages of collaboration in the cloud. Signavio is headquartered in Berlin and has offices in Sunnyvale, CA and Singapore. For more information, please visit www.signavio.com .
About Summit Partners
Founded in 1984, Summit Partners is a global growth equity firm that is currently investing more than $6.5 billion into equity and fixed income opportunities. Summit has invested in more than 400 companies in technology, healthcare and other growth sectors. These companies have completed more than 135 public offerings, and more than 150 have been acquired through strategic mergers and sales. Signavio is Summit’s third European software investment in 2015, following partnerships with DarkTrace and RELEX. Other notable technology companies financed by Summit Partners include Avast, Belkin, Clearwater Analytics, Flow Traders, Hyperion Solutions, Infor, McAfee, NetWitness, Postini, RiskIQ, SafeBoot, Uber and WebEx. Summit maintains offices in North America and Europe and invests in companies around the world. For more information, visit www.summitpartners.com or follow on Twitter at @SummitPartners
In the United States of America, Summit Partners operates as an SEC-registered investment advisor. In the United Kingdom, this document is issued by Summit Partners LLP, a firm authorized and regulated by the Financial Conduct Authority. Summit Partners LLP is a limited liability partnership registered in England and Wales with registered number OC388179 and its registered office is at 20–22 Bedford Row, London, WC1R 4JS, UK. This document is intended solely to provide information regarding Summit Partners’ potential financing capabilities for prospective portfolio companies.
+49 30 856 21 54 12
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
DE-INCYTE21.10.2018 12:47 | pressemeddelelse
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma
SERVIER21.10.2018 11:12 | pressemeddelelse
Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum